September 26, 2016 11:09 AM ET


Company Overview of Envoy Therapeutics, Inc.

Key Executives for Envoy Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Brad A. Margus 48 RelationshipsCo-Founder, Chief Executive Officer and Director55
Jeffrey Friedman M.D., Ph.D.15 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Paul Greengard Ph.D.83 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Nathanial Heintz Ph.D.No RelationshipsCo-Founder--
Nobel Laureate No RelationshipsFounder--
View More Key Executives

Envoy Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John D. Diekman Ph.D. 139 Relationships5AM Venture Management LLC73
Brad A. Margus 48 RelationshipsEnvoy Therapeutics, Inc.55
Jeffrey Friedman M.D., Ph.D. 15 RelationshipsEnvoy Therapeutics, Inc.--
Paul Greengard Ph.D. 83 RelationshipsIntra-Cellular Therapies, Inc.--
William Warren Bradley 200 Relationships5AM Venture Management LLC73
View All Board Members

Envoy Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Envoy Therapeutics, Inc. CEO Compensation
Industry Average


Nouscom Announces Management Appointments
September 26, 2016 6:00 AM ET
Tyche Industries Ltd Announces the Resignation of G Sandeep as Whole Time Director and Chief Financial Officer
September 24, 2016 12:00 AM ET
Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Envoy Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at